|
| |
Miller G, Heighway J and R.H. Crosbie "The Identification and Characterization of Microspan: a Novel Isoform of Sarcospan" Under review. Miller G, Lipman K, Wang E & RH Crosbie "Structural Determinants Mediating Sarcospan-Sarcoglycan Interactions." In preparation. Miller G, Musa H, Gautel M and Peckham M. (2003)."A targeted deletion of the C-terminal end of titin, including the titin kinase domain, impairs myofibrillogenesis." J. Cell Sci., 116, 4811-4819. Miller G, Maycock J, White E, Peckham M and Calaghan S. (2003) "Heterologous expression of wild type and mutant b-cardiac myosin changes the contraction kinetics of cultured myotubes." J. Physiol 548.1, 167-174. Yi C, Bekker JM, Miller G, Hill K and Crosbie RH. (2003) "Specific and potent RNA interference in terminally differentiated myotubes. J. Biol. Chem, 278, 934-939. Peckham M, Miller G, Wells C, Zicha D and Dunn G. (2001). Specific changes to the mechanism of cell locomotion induced by overexpression of ß-actin. J. Cell Sci., 114, 1367-1377. See also http://www.nature.com/nsu/010329/010329-10.html Miller G, Colegrave M and Peckham M. (2000). N232S, G741R & D778G ß-cardiac myosin mutants implicated in familial hypertrophic cardiomyopathy, do not disrupt myofibrillar organisation in cultured myotubes. FEBS Letters, 486, 325-327. Miller G, Steinbrecher RA, Murdock PJ, Tuddenham EGD, Lee CA, Pasi KJ and Goldspink G. (1995). Expression of Factor VII by Muscle Cells in vitro and in vivo following Direct Gene Transfer: Modelling Gene Therapy for Haemophilia. Gene Therapy; 2:736-742.
|
||||||||||||||||||||||||||||||||||||||
|
The Crosbie Lab, UCLA |
Designed By: Jessica Wood |